Target N V Biotech Esperion Therapeutics, Inc. (ESPR) insider trading activity
Target N V Biotech is > 10% Shareholder of Esperion Therapeutics, Inc.. Currently has a direct ownership of 4.48 Million shares of ESPR, which is worth approximately $7.84 Million. The most recent transaction as insider was on May 24, 2021, when has been sold 100,000 shares (Common Stock) at a price of $20.22 per share, resulting in proceeds of $2,022,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
4.48M
0%
3M change
0%
12M change
Total Value Held
$7.84 Million
TARGET N V BIOTECH Transaction History
Also insider at
TNV
Target N V Biotech
> 10% Shareholder
Curacao, P8